The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

aTyr Pharma Inc

Nasdaq: LIFE
Last

(U.S.) $3.48

Today's change0.00 0.00%
Updated May 3 4:00 PM EDT. Delayed by at least 15 minutes.
 

aTyr Pharma Inc

Nasdaq: LIFE
Last

(U.S.) $3.48

Today's change0.00 0.00%
Updated May 3 4:00 PM EDT. Delayed by at least 15 minutes.

aTyr Pharma Inc closed at (U.S.)$3.48.

Over the last five days, shares have lost 10.08% and are down 64.60% for the last year to date. This security has underperformed the S&P 500 by 90.58% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $3.48
  • High--
  • Low--
  • Bid / Ask(U.S.) $0.00 / (U.S.) $3.99
  • YTD % change-64.60%
  • Volume0
  • Average volume (10-day)344,211
  • Average volume (1-month)716,167
  • Average volume (3-month)320,181
  • 52-week range(U.S.) $3.03 to (U.S.) $28.29
  • Beta--
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$2.04
Updated May 3 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue------0
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense1611119
Selling / general / administrative4432
Research & development13887
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0------
Other operating expenses, total--------
Operating income-16-11-11-9
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-16-11-11-9
Income after tax-16-11-11-9
Income tax, total--------
Net income-16-11-11-9
Total adjustments to net income0000
Net income before extra. items-16-11-11-9
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-16-11-11-9
Inc. avail. to common incl. extra. items-16-11-11-9
Diluted net income-16-11-11-9
Dilution adjustment------0
Diluted weighted average shares24242423
Diluted EPS excluding extraordinary itemsvalue per share-0.69-0.48-0.47-0.40
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.70-0.48-0.47-0.40